Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.375 USD | +7.95% | +6.03% | -65.68% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.68% | 58.09M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-8.92% | 33.03B | |
+55.32% | 24.68B | |
-16.50% | 15.12B | |
-8.84% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- IMMX Stock
- News Immix Biopharma, Inc.
- Immix Says Median Progression-Free Survival Not Yet Reached in Trial of IMX-110 Plus Tislelizumab in Colorectal Cancer